PIM
EW icon

Provident Investment Management’s Edwards Lifesciences EW Stock Holding History

Provident Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-447,549
Closed -$41.3M – 81
2024
Q2 		$41.3M Sell
447,549
-5,781
-1% -$512K 3.76% 16
2024
Q1 		$43.3M Sell
453,330
-2,400
-0.5% -$202K 3.82% 17
2023
Q4 		$34.7M Buy
455,730
+6,837
+2% +$476K 3.28% 15
2023
Q3 		$31.1M Buy
448,893
+16,742
+4% +$1.35M 3.43% 15
2023
Q2 		$40.8M Sell
432,151
-525
-0.1% -$45.6K 4.31% 14
2023
Q1 		$35.8M Buy
+432,676
New +$34M 3.88% 16

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Provident Investment Management's EW Position: Q3 2024 in Review

Provident Investment Management sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 447,549 shares — an estimated $41.3M sold.

Provident Investment Management first reported a position in EW in Q1 2023 and held it in 6 quarters. The position peaked at $43.3M in Q1 2024. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Provident Investment Management reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Provident Investment Management sold 447,549 Edwards Lifesciences shares in Q3 2024, an estimated $41.3M.
  • Provident Investment Management first reported a position in Edwards Lifesciences in Q1 2023 and held it in 6 quarters.
  • Provident Investment Management's Edwards Lifesciences position peaked at $43.3M in Q1 2024.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Provident Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.